Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Castagna

Showing results (301-310 of 467) with videos related to

Pageof 47
Sort By:
International Journal of Antimicrobial Agents|December 6, 2021
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIVDaniele Armenia, Maria Mercedes Santoro, Maria Concetta Bellocchi, et al.
Antiviral Therapy|February 5, 2008
Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutationAndrea Antinori, Maria Paola Trotta, Patrizia Lorenzini, et al.
Drug Design, Development and Therapy|July 5, 2022
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical PracticeMartina Ranzenigo, Nicola Gianotti, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 13, 2016
Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized TherapyAntonio Di Biagio, Alessandro Cozzi-Lepri, Roberta Prinapori, et al.
AIDS (London, England)|May 6, 2025
Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIVTommaso Clemente, Michele Bellomo, Angelo Roberto Raccagni, et al.
AIDS (London, England)|May 28, 2026
Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registryAndrea Calcagno, Martina Strano, Riccardo Lolatto, et al.
Sexually Transmitted Diseases|April 22, 2024
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Between 2012 and 2023: Results From an Open Italian CohortMaria Francesca Lucente, Angelo Roberto Raccagni, Laura Galli, et al.
Medicine|July 19, 2016
Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patientsFrancesca Ferretti, Alba Bigoloni, Laura Passeri, et al.
Open Forum Infectious Diseases|November 5, 2024
Breakthrough Rectal <i>Neisseria gonorrhoeae</i> Infections After Meningococcal B Vaccination: Microbiological and Clinical FeaturesAngelo Roberto Raccagni, Sara Diotallevi, Riccardo Lolatto, et al.
Medicine|November 19, 2016
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progressionAntonella Castagna, Laura Monno, Stefania Carta, et al.
Pageof 47

Showing results (301-310 of 467) with videos related to

Sort By:
Pageof 47
International Journal of Antimicrobial Agents|December 6, 2021
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIVDaniele Armenia, Maria Mercedes Santoro, Maria Concetta Bellocchi, et al.
Antiviral Therapy|February 5, 2008
Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutationAndrea Antinori, Maria Paola Trotta, Patrizia Lorenzini, et al.
Drug Design, Development and Therapy|July 5, 2022
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical PracticeMartina Ranzenigo, Nicola Gianotti, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 13, 2016
Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized TherapyAntonio Di Biagio, Alessandro Cozzi-Lepri, Roberta Prinapori, et al.
AIDS (London, England)|May 6, 2025
Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIVTommaso Clemente, Michele Bellomo, Angelo Roberto Raccagni, et al.
AIDS (London, England)|May 28, 2026
Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registryAndrea Calcagno, Martina Strano, Riccardo Lolatto, et al.
Sexually Transmitted Diseases|April 22, 2024
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Between 2012 and 2023: Results From an Open Italian CohortMaria Francesca Lucente, Angelo Roberto Raccagni, Laura Galli, et al.
Medicine|July 19, 2016
Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patientsFrancesca Ferretti, Alba Bigoloni, Laura Passeri, et al.
Open Forum Infectious Diseases|November 5, 2024
Breakthrough Rectal <i>Neisseria gonorrhoeae</i> Infections After Meningococcal B Vaccination: Microbiological and Clinical FeaturesAngelo Roberto Raccagni, Sara Diotallevi, Riccardo Lolatto, et al.
Medicine|November 19, 2016
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progressionAntonella Castagna, Laura Monno, Stefania Carta, et al.
Pageof 47